NASDAQ: UTHRUnited Therapeutics Corp Stock Ownership - Who owns United Therapeutics?
Insider buying vs selling
Have United Therapeutics Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 870 | $295.12 | $256.76kSell |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 239 | $297.00 | $70.98kSell |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 300 | $298.05 | $89.42kSell |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 500 | $299.05 | $149.52kSell |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 1,320 | $300.63 | $396.83kSell |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 3,392 | $301.81 | $1.02MSell |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 3,859 | $302.71 | $1.17MSell |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 120 | $303.38 | $36.41kSell |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 11,000 | $117.76 | $1.30MBuy |
| Paul A. Mahon | EVP GENERAL COUNSEL | 2025-05-01 | 400 | $296.00 | $118.40kSell |
UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when UTHR insiders and whales buy or sell their stock.
UTHR Shareholders
What type of owners hold United Therapeutics Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Wealthfront Advisers LLC | 40.60% | 18,314,300 | $5.52B | Institution |
| Blackrock Inc | 11.88% | 5,358,332 | $1.62B | Institution |
| Lilly Co Eli | 11.64% | 5,251,394 | $1.58B | Insider |
| Vanguard Group Inc | 9.85% | 4,441,823 | $1.34B | Institution |
| Avoro Capital Advisors LLC | 6.12% | 2,760,300 | $832.01M | Institution |
| Wellington Management Group LLP | 5.46% | 2,463,891 | $742.67M | Institution |
| State Street Corp | 4.88% | 2,199,994 | $663.12M | Institution |
| Renaissance Technologies LLC | 4.63% | 2,089,392 | $629.78M | Institution |
| Fmr LLC | 3.26% | 1,471,405 | $443.51M | Institution |
| Geode Capital Management LLC | 2.52% | 1,138,292 | $343.10M | Institution |
UTHR vs Biotech Stocks
United Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.